Complement activation and complement control proteins in acute pancreatitis.
Open Access
- 1 November 1982
- Vol. 23 (11) , 944-950
- https://doi.org/10.1136/gut.23.11.944
Abstract
Serum levels of the complement proteins C3, C4, C1 inhibitor (C1 INH), factor I (C3b inactivator) and factor H (BIH) and plasma levels of cleavage products of C3 (C3c) and factor B were measured in 26 patients with acute pancreatitis. Breakdown of C3 occurred in 19 patients, as shown by a reduction in C3 level and the presence of C3c. C4 levels, however, did not fall and factor B breakdown products were not detected, thus suggesting that enzymatic cleavage of C3 occurred without significant involvement of either the early classical pathway or the alternative pathway. C1 INH and factor H both showed increases, presumably reflecting an acute phase response. Factor I showed an initial fall followed by a rise. There was no correlation between the presence or extent of C3 breakdown and the clinical condition of the patients. It is concluded that C3 cleavage in pancreatitis probably results from tryptic activity and that the measurement of complement components has no part to play in the management of the disease.This publication has 17 references indexed in Scilit:
- SERUM COMPLEMENT FACTORS IN HUMAN ACUTE-PANCREATITIS1981
- Clinical applications of immunofixation: detection and quantitation of complement activation.Journal of Clinical Pathology, 1980
- Evidence of complement catabolism in acute pancreatitisThe Lancet Healthy Longevity, 1978
- Complement system in sodium taurocholate pancreatitis in the ratZeitschrift für Die Gesamte Experimentelle Medizin, 1978
- The serum complement system ? a mediator of acute pancreatitisVirchows Archiv, 1975
- Experimental Pancreatitis in the Dog. Demonstration of Trypsin in Ascitic Fluid, Lymph and PlasmaScandinavian Journal of Gastroenterology, 1973
- Experimental Pancreatitis in the Dog. Appearance of Complexes Between Proteases and Trypsin Inhibitors in Ascitic Fluid, Lymph, and PlasmaScandinavian Journal of Gastroenterology, 1971
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1968
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965